Synthesis of 3′-azido-2′,3′-dideoxy-5-fluorouridine phosphoramidates and evaluation of their anticancer activity

被引:19
|
作者
Lewandowska, Marta [1 ]
Ruszkowski, Piotr [2 ]
Baraniak, Dagmara [1 ]
Czarnecka, Anna [1 ]
Kleczewska, Natalia [1 ]
Celewicz, Lech [1 ]
机构
[1] Adam Mickiewicz Univ, Fac Chem, PL-60780 Poznan, Poland
[2] Poznan Univ Med Sci, Dept Pharmacol, PL-60806 Poznan, Poland
关键词
3; '-Azido-2; 3 '-dideoxy-5-fluorouridine phosphoramidates; Phosphorylation; Cytotoxic activity; Human cancer cell lines: HeLa; KB and MCF-7; NUCLEOSIDE ANALOGS; BIOLOGICAL-ACTIVITY; PYRIMIDINE DEOXYRIBONUCLEOSIDES; ANTIVIRAL ACTIVITY; TRIESTER METHOD; IN-VIVO; 5-FLUORO-2'-DEOXYURIDINE; CELLS; 5-FLUOROURACIL; CYTOTOXICITY;
D O I
10.1016/j.ejmech.2013.06.047
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
A series of novel 4-chlorophenyl N-alkyl phosphoramidates of 3'-azido-2',3'-dideoxy-5-fluorouridine (12-21) were synthesized by means of phosphorylation of 3'-azido-2',3'-dideoxy-5-fluorouridine (4) with 4-chlorophenyl phosphoroditriazolide (10) followed by a reaction with the appropriate amine. The synthesized phosphoramidates (12-21) were evaluated for their cytotoxic activity in three human cancer cell lines: cervical (HeLa), oral (KB) and breast (MCF-7) using the sulforhodamine B (SRB) assay. The highest activity in all the investigated cancer cells was displayed by phosphoramidate 13 with the N-ethyl substituent and its activity was much higher than that of the parent nucleoside. Also phosphoramidate 17 with the N-propargyl substituent exhibited good activity in all the used cell lines. (C) 2013 Elsevier Masson SAS. All rights reserved.
引用
收藏
页码:188 / 195
页数:8
相关论文
共 50 条
  • [11] NEW STRATEGIES IN THE SYNTHESIS OF 3'-AZIDO-2',3'-DIDEOXY-NUCLEOSIDES WITH FURANOSE CONFIGURATION
    WENGEL, J
    LAU, J
    WALCZAK, K
    PEDERSEN, EB
    NUCLEOSIDES & NUCLEOTIDES, 1991, 10 (1-3): : 405 - 408
  • [12] NEW ROUTE FOR THE SYNTHESIS OF 2-THIOURACIL ANALOGS OF 3'-AZIDO-2',3'-DIDEOXY NUCLEOSIDES
    ELTORGOMAN, AM
    MOTAWIA, MS
    KJAERSGAARD, U
    PEDERSEN, EB
    MONATSHEFTE FUR CHEMIE, 1992, 123 (04): : 355 - 361
  • [13] SYNTHESIS AND ANTIVIRAL ACTIVITY OF SEVERAL 2,5'-ANHYDRO ANALOGS OF AZT, 3'-AZIDO-2',3'-DIDEOXYURIDINE (AZU),3'- AZIDO-2',3'-DIDEOXY-5-HALOURIDINES, AND 3'-DEOXYTHYMIDINE AGAINST HIV-1 AND R-MULV
    LIN, TS
    SHEN, ZY
    AUGUST, ME
    PRUSOFF, WH
    BRANKOVAN, V
    YANG, HY
    GHAZZOULI, I
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 1989, 197 : 30 - CARB
  • [14] SYNTHESIS OF 3'-AZIDO-2',3'-DIDEOXYRIBOFURANOSYLPURINES
    IMAZAWA, M
    ECKSTEIN, F
    JOURNAL OF ORGANIC CHEMISTRY, 1978, 43 (15): : 3044 - 3048
  • [16] FLUORINATED PYRIMIDINES .29. SYNTHESES OF 2',3'-DEHYDRO-5-FLUORO-2'-DEOXYURIDINE AND 2',3'-DIDEOXY-5-FLUOROURIDINE
    KHWAJA, TA
    HEIDELBERGER, C
    JOURNAL OF MEDICINAL CHEMISTRY, 1967, 10 (06) : 1066 - +
  • [17] SYNTHESIS AND ANTIVIRAL ACTIVITY OF SEVERAL 2,5'-ANHYDRO ANALOGS OF 3'-AZIDO-3'-DEOXYTHYMIDINE, 3'-AZIDO-2',3'-DIDEOXYURIDINE, 3'-AZIDO-2',3'-DIDEOXY-5-HALOURIDINES, AND 3'-DEOXYTHYMIDINE AGAINST HUMAN IMMUNODEFICIENCY VIRUS AND RAUSCHER-MURINE LEUKEMIA-VIRUS
    LIN, TS
    SHEN, ZY
    AUGUST, EM
    BRANKOVAN, V
    YANG, HY
    GHAZZOULI, I
    PRUSOFF, WH
    JOURNAL OF MEDICINAL CHEMISTRY, 1989, 32 (08) : 1891 - 1895
  • [18] RELATIONSHIP BETWEEN CONFORMATION AND ANTIVIRAL ACTIVITY .3. 3'-AZIDOTHYMIDINE (AZT) AND 3'-AZIDO-2',3'-DIDEOXY-5-HYDROXYMETHYLURIDINE
    GUPTA, SV
    KUMAR, SVP
    STUART, AL
    SHI, R
    BROWN, KC
    ZOGHAIB, WM
    LI, J
    DELBAERE, LTJ
    NUCLEOSIDES & NUCLEOTIDES, 1995, 14 (08): : 1675 - 1691
  • [19] Novel Exocyclic Nucleoside Related to Clitocine: A Convergent Synthesis of 3′-Azido-2′,3′-dideoxy Clitocine
    Guo, Xianghai
    Liu, Can
    Zheng, Lanxi
    Jiang, Shende
    Shen, Jiaxiang
    SYNLETT, 2010, (13) : 1959 - 1962
  • [20] Pharmacokinetics and tissue distribution of (±)-3′-azido-2′,3′-dideoxy-5′-O-(2-bromomyristoyl)thymidine a prodrug of 3′-azido-2′,3′-dideoxythymidine (AZT) in mice
    Parang, K
    Wiebe, LI
    Knaus, EE
    JOURNAL OF PHARMACY AND PHARMACOLOGY, 1998, 50 (09) : 989 - 996